Rise in prevalence of chronic disorders and technological advancements in healthcare sector are fueling the apheresis market size. Apheresis helps in blood filtration and purification, thereby being used in various medical treatments conducted for cancers, arthritis, diabetes, and renal diseases.
Moreover, surge in prevalence of cardiovascular diseases among geriatric population is fostering market expansion.
Leading players in the market are improving their product portfolios by launching new products with advanced technologies to get optimized results.
They are signing business agreements to globalize their brands and meet customer demands. Companies in this industry focus on research and development to produce innovative medical devices used in apheresis procedures.
Apheresis is a medical procedure that separates one or more blood components from a person’s blood and returns the rest to circulation. It is also known as pheresis or hemapheresis.
Apheresis can collect stem cells, plasma, platelets, or white blood cells for medical treatment. The process involves withdrawing blood from a donor, passing it through an apparatus that uses a centrifuge to separate the blood elements, and then transfusing the remaining blood back into the donor.
Automated apheresis systems advancements are employed in cell and gene therapies, CAR-T cell therapies, sickle cell disease, and symptom management. These systems are utilized in therapeutic interventions and the development of cell-based therapies to improve patient outcomes.
| Attribute | Detail |
|---|---|
| Drivers |
|
Changing lifestyles, lack of physical activities, and poor diet are leading to chronic diseases including, asthma, diabetes, chronic obstructive pulmonary disease, and chronic kidney disease. Apheresis does not cure these diseases, but it can improve a patient’s quality of life by ensuring adequate blood filtration.
Apheresis is beneficial in managing glomerulonephritis, a group of kidney diseases characterized by inflammation of the glomeruli. By removing harmful antibodies and immune complexes, apheresis helps stabilize renal function. Thus, rise in prevalence of chronic disorders is bolstering the apheresis market statistics.
According to the World Health Organization, 41 million fatalities are accounted every year which is equivalent to 74% of all deaths due to Noncommunicable Diseases (NCD) across the globe.
Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes). Hence, surge in prevalence of these diseases is propelling the apheresis market revenue.
Therapeutic plasma exchange apheresis techniques are enhanced due to technological advancements in healthcare sector. Apheresis is used for plasma exchange in various chronic conditions.
It helps remove toxic substances, autoantibodies, and cytokines by replacing a patient’s plasma with donor plasma or albumin. Thus, technological advancements in healthcare sector are augmenting the apheresis market value.
Implementation of stringent apheresis nursing care protocols is driving the demand for appropriate training sessions among healthcare professionals.
Pre-domination assessment, pre-collection assessment, and post-run rinse back are crucial factors in apheresis procedures. Hence, rise in demand for improved patient care management systems is boosting market development.
| Attribute | Detail |
|---|---|
| Leading Region | Asia Pacific |
As per the latest apheresis market analysis, Asia Pacific dominated the global market in 2023. Rise in prevalence of chronic diseases and increase in expenditure on medical facilities are likely to drive the apheresis industry share during the forecast period.
Moreover, increase in number of complicated surgical procedures and number of organ donors are driving the market progress.
According to the National Institutes of Health, cardiovascular disease accounts for around 60% of all deaths globally of which India accounts for one-fifth of these deaths especially in younger population.
Advancements in healthcare facilities are some of the recent apheresis market trends. Leading players in the market are focusing on adopting multiple strategies to improve their business performance.
Companies are launching new medical equipment required in apheresis procedures to ensure optimized results. Moreover, they are signing business agreements to increase their brand presence in global markets.
Some of the players in the industry are Terumo Corporation, Fresenius Kabi AG, B. Braun SE, NIKKISO Co., Ltd., Medica SPA., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories America, and Therakos, Inc.
These companies have been profiled in the apheresis market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 2.9 Bn |
| Market Forecast (Value) in 2034 | US$ 6.7 Bn |
| Growth Rate (CAGR) | 7.7% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 2.9 Bn in 2023
It is projected to register a CAGR of 7.7% from 2024 to 2034
Rise in prevalence of chronic disorders and technological advancements in healthcare sector
Asia Pacific was the most lucrative region in 2023
Terumo Corporation, Fresenius Kabi AG, B. Braun SE, NIKKISO Co., Ltd., Medica SPA., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories America, and Therakos, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Apheresis Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Apheresis Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Apheresis Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Devices
6.3.2. Disposables
6.4. Market Attractiveness, by Product Type
7. Global Apheresis Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Renal Diseases
7.3.2. Neurology
7.3.3. Hematology
7.3.4. Cancer
7.3.5. Autoimmune Disease
7.3.6. Cardiovascular Diseases
7.3.7. Others
7.4. Market Attractiveness, by Application
8. Global Apheresis Market Analysis and Forecast, by Procedure
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Procedure, 2020-2034
8.3.1. Plasmapheresis
8.3.2. Photopheresis
8.3.3. LDL-apheresis
8.3.4. Plateletpheresis
8.3.5. Leukapheresis
8.3.6. Erythrocytapheresis
8.3.7. Others
8.4. Market Attractiveness, by Procedure
9. Global Apheresis Market Analysis and Forecast, by Technology
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Technology, 2020-2034
9.3.1. Centrifugation
9.3.2. Membrane Filtration
9.4. Market Attractiveness, by Technology
10. Global Apheresis Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2034
10.3.1. Hospitals
10.3.2. Blood Collection Centers
10.3.2.1. Public
10.3.2.2. Private
10.4. Market Attractiveness, by End-user
11. Global Apheresis Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2034
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Apheresis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Devices
12.2.2. Disposables
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Renal Diseases
12.4.2. Neurology
12.4.3. Hematology
12.4.4. Cancer
12.4.5. Autoimmune Disease
12.4.6. Cardiovascular Diseases
12.4.7. Others
12.5. Market Attractiveness, by Application
12.6. Market Value Forecast, by Procedure, 2020-2034
12.6.1. Plasmapheresis
12.6.2. Photopheresis
12.6.3. LDL-apheresis
12.6.4. Plateletpheresis
12.6.5. Leukapheresis
12.6.6. Erythrocytapheresis
12.6.7. Others
12.7. Market Attractiveness, by Procedure
12.8. Market Value Forecast, by Technology, 2020-2034
12.8.1. Centrifugation
12.8.2. Membrane Filtration
12.9. Market Attractiveness, by Technology
12.10. Market Value Forecast, by End-user, 2020-2034
12.10.1. Hospitals
12.10.2. Blood Collection Centers
12.10.2.1. Public
12.10.2.2. Private
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Product Type
12.13.2. By Application
12.13.3. by Procedure
12.13.4. By Animal Type
12.13.5. By End-user
12.13.6. By Country
13. Europe Apheresis Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Devices
13.2.2. Disposables
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Renal Diseases
13.4.2. Neurology
13.4.3. Hematology
13.4.4. Cancer
13.4.5. Autoimmune Disease
13.4.6. Cardiovascular Diseases
13.4.7. Others
13.5. Market Attractiveness, by Application
13.6. Market Value Forecast, by Procedure, 2020-2034
13.6.1. Plasmapheresis
13.6.2. Photopheresis
13.6.3. LDL-apheresis
13.6.4. Plateletpheresis
13.6.5. Leukapheresis
13.6.6. Erythrocytapheresis
13.6.7. Others
13.7. Market Attractiveness, by Procedure
13.8. Market Value Forecast, by Technology, 2020-2034
13.8.1. Centrifugation
13.8.2. Membrane Filtration
13.9. Market Attractiveness, by Technology
13.10. Market Value Forecast, by End-user, 2020-2034
13.10.1. Hospitals
13.10.2. Blood Collection Centers
13.10.2.1. Public
13.10.2.2. Private
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Product Type
13.13.2. By Application
13.13.3. by Procedure
13.13.4. By Animal Type
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Apheresis Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Devices
14.2.2. Disposables
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Renal Diseases
14.4.2. Neurology
14.4.3. Hematology
14.4.4. Cancer
14.4.5. Autoimmune Disease
14.4.6. Cardiovascular Diseases
14.4.7. Others
14.5. Market Attractiveness, by Application
14.6. Market Value Forecast, by Procedure, 2020-2034
14.6.1. Plasmapheresis
14.6.2. Photopheresis
14.6.3. LDL-apheresis
14.6.4. Plateletpheresis
14.6.5. Leukapheresis
14.6.6. Erythrocytapheresis
14.6.7. Others
14.7. Market Attractiveness, by Procedure
14.8. Market Value Forecast, by Technology, 2020-2034
14.8.1. Centrifugation
14.8.2. Membrane Filtration
14.9. Market Attractiveness, by Technology
14.10. Market Value Forecast, by End-user, 2020-2034
14.10.1. Hospitals
14.10.2. Blood Collection Centers
14.10.2.1. Public
14.10.2.2. Private
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Product Type
14.13.2. By Application
14.13.3. by Procedure
14.13.4. By Animal Type
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Apheresis Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Devices
15.2.2. Disposables
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Application, 2020-2034
15.4.1. Renal Diseases
15.4.2. Neurology
15.4.3. Hematology
15.4.4. Cancer
15.4.5. Autoimmune Disease
15.4.6. Cardiovascular Diseases
15.4.7. Others
15.5. Market Attractiveness, by Application
15.6. Market Value Forecast, by Procedure, 2020-2034
15.6.1. Plasmapheresis
15.6.2. Photopheresis
15.6.3. LDL-apheresis
15.6.4. Plateletpheresis
15.6.5. Leukapheresis
15.6.6. Erythrocytapheresis
15.6.7. Others
15.7. Market Attractiveness, by Procedure
15.8. Market Value Forecast, by Technology, 2020-2034
15.8.1. Centrifugation
15.8.2. Membrane Filtration
15.9. Market Attractiveness, by Technology
15.10. Market Value Forecast, by End-user, 2020-2034
15.10.1. Hospitals
15.10.2. Blood Collection Centers
15.10.2.1. Public
15.10.2.2. Private
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Product Type
15.13.2. By Application
15.13.3. by Procedure
15.13.4. By Animal Type
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Apheresis Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product Type, 2020-2034
16.2.1. Devices
16.2.2. Disposables
16.3. Market Attractiveness, by Product Type
16.4. Market Value Forecast, by Application, 2020-2034
16.4.1. Renal Diseases
16.4.2. Neurology
16.4.3. Hematology
16.4.4. Cancer
16.4.5. Autoimmune Disease
16.4.6. Cardiovascular Diseases
16.4.7. Others
16.5. Market Attractiveness, by Application
16.6. Market Value Forecast, by Procedure, 2020-2034
16.6.1. Plasmapheresis
16.6.2. Photopheresis
16.6.3. LDL-apheresis
16.6.4. Plateletpheresis
16.6.5. Leukapheresis
16.6.6. Erythrocytapheresis
16.6.7. Others
16.7. Market Attractiveness, by Procedure
16.8. Market Value Forecast, by Technology, 2020-2034
16.8.1. Centrifugation
16.8.2. Membrane Filtration
16.9. Market Attractiveness, by Technology
16.10. Market Value Forecast, by End-user, 2020-2034
16.10.1. Hospitals
16.10.2. Blood Collection Centers
16.10.2.1. Public
16.10.2.2. Private
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2020-2034
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Product Type
16.13.2. By Application
16.13.3. by Procedure
16.13.4. By Animal Type
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
17.3.1. Terumo Corporation
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Fresenius Kabi AG.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. B. Braun SE
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. NIKKISO Co., Ltd.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Medica SPA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Asahi Kasei Medical Co. Ltd.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Haemonetics Corporation
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Cerus Corporation
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Kawasumi Laboratories America
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Therakos, Inc.
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
List of Tables
Table 01: Global Apheresis Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 02: Global Apheresis Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Apheresis Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 04: Global Apheresis Market Size (US$ Mn) Forecast, by Procedure, 2020-2034
Table 05: Global Apheresis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 06: Global Apheresis Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 07: North America Apheresis Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 08: North America Apheresis Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 09: North America Apheresis Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 10: North America Apheresis Market Size (US$ Mn) Forecast, by Procedure, 2020-2034
Table 11: North America Apheresis Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 12: North America Apheresis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Europe Apheresis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Europe Apheresis Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 15: Europe Apheresis Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Europe Apheresis Market Size (US$ Mn) Forecast, by Procedure, 2020-2034
Table 17: Europe Apheresis Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 18: Europe Apheresis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 19: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 20: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 21: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 22: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, by Procedure, 2020-2034
Table 23: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 24: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 25: Latin America Apheresis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 26: Latin America Apheresis Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 27: Latin America Apheresis Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 28: Latin America Apheresis Market Size (US$ Mn) Forecast, by Procedure, 2020-2034
Table 29: Latin America Apheresis Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 30: Latin America Apheresis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 31: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 32: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 33: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 34: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast, by Procedure, 2020-2034
Table 35: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 36: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Apheresis Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Apheresis Market Revenue (US$ Mn), by Product Type, 2023
Figure 03: Global Apheresis Market Value Share, by Product Type, 2023
Figure 04: Global Apheresis Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global Apheresis Market Value Share, by Application, 2023
Figure 06: Global Apheresis Market Revenue (US$ Mn), by Procedure, 2023
Figure 07: Global Apheresis Market Value Share, by Procedure, 2023
Figure 08: Global Apheresis Market Revenue (US$ Mn), by Technology, 2023
Figure 09: Global Apheresis Market Value Share, by Technology, 2023
Figure 10: Global Apheresis Market Revenue (US$ Mn), by End-user, 2023
Figure 11: Global Apheresis Market Value Share, by End-user, 2023
Figure 12: Global Apheresis Market Value Share, by Region, 2023
Figure 13: Global Apheresis Market Value (US$ Mn) Forecast, 2020-2034
Figure 14: Global Apheresis Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 15: Global Apheresis Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 16: Global Apheresis Market Value Share Analysis, by Application, 2023 and 2034
Figure 17: Global Apheresis Market Attractiveness Analysis, by Application, 2024-2034
Figure 18: Global Apheresis Market Value Share Analysis, by Procedure, 2023 and 2034
Figure 19: Global Apheresis Market Attractiveness Analysis, by Procedure, 2024-2034
Figure 20: Global Apheresis Market Revenue (US$ Mn), by Technology, 2023
Figure 21: Global Apheresis Market Value Share, by Technology, 2023
Figure 22: Global Apheresis Market Revenue (US$ Mn), by End-user, 2023
Figure 23: Global Apheresis Market Value Share, by End-user, 2023
Figure 24: Global Apheresis Market Value Share Analysis, by Region, 2023 and 2034
Figure 25: Global Apheresis Market Attractiveness Analysis, by Region, 2024-2034
Figure 26: North America Apheresis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 27: North America Apheresis Market Attractiveness Analysis, by Country, 2024-2034
Figure 28: North America Apheresis Market Value Share Analysis, by Country, 2023 and 2034
Figure 29: North America Apheresis Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 30: North America Apheresis Market Value Share Analysis, by Application, 2023 and 2034
Figure 31: North America Apheresis Market Value Share Analysis, by Procedure, 2023 and 2034
Figure 32: North America Apheresis Market Value Share Analysis, by Technology, 2023 and 2034
Figure 33: North America Apheresis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 34: North America Apheresis Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 35: North America Apheresis Market Attractiveness Analysis, by Application, 2024-2034
Figure 36: North America Apheresis Market Attractiveness Analysis, by Procedure, 2023-2034
Figure 37: North America Apheresis Market Attractiveness Analysis, by Technology, 2024-2034
Figure 38: North America Apheresis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 39: Europe Apheresis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 40: Europe Apheresis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 41: Europe Apheresis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 42: Europe Apheresis Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 43: Europe Apheresis Market Value Share Analysis, by Application, 2023 and 2034
Figure 44: Europe Apheresis Market Value Share Analysis, by Procedure, 2023 and 2034
Figure 45: Europe Apheresis Market Value Share Analysis, by Technology, 2023 and 2034
Figure 46: Europe Apheresis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 47: Europe Apheresis Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 48: Europe Apheresis Market Attractiveness Analysis, by Application, 2024-2034
Figure 49: Europe Apheresis Market Attractiveness Analysis, by Procedure, 2024-2034
Figure 50: Europe Apheresis Market Attractiveness Analysis, by Technology, 2024-2034
Figure 51: Europe Apheresis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 52: Asia Pacific Apheresis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 53: Asia Pacific Apheresis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 54: Asia Pacific Apheresis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 55: Asia Pacific Apheresis Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 56: Asia Pacific Apheresis Market Value Share Analysis, by Application, 2023 and 2034
Figure 57: Asia Pacific Apheresis Market Value Share Analysis, by Procedure, 2023 and 2034
Figure 58: Asia Pacific Apheresis Market Value Share Analysis, by Technology, 2023 and 2034
Figure 59: Asia Pacific Apheresis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Asia Pacific Apheresis Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 61: Asia Pacific Apheresis Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Asia Pacific Apheresis Market Attractiveness Analysis, by Procedure, 2024-2034
Figure 63: Asia Pacific Apheresis Market Attractiveness Analysis, by Technology, 2024-2034
Figure 64: Asia Pacific Apheresis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 65: Latin America Apheresis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 66: Latin America Apheresis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 67: Latin America Apheresis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 68: Latin America Apheresis Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 69: Latin America Apheresis Market Value Share Analysis, by Application, 2023 and 2034
Figure 70: Latin America Apheresis Market Value Share Analysis, by Procedure, 2023 and 2034
Figure 71: Latin America Apheresis Market Value Share Analysis, by Technology, 2023 and 2034
Figure 72: Latin America Apheresis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 73: Latin America Apheresis Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 74: Latin America Apheresis Market Attractiveness Analysis, by Application, 2024-2034
Figure 75: Latin America Apheresis Market Attractiveness Analysis, by Procedure, 2023-2034
Figure 76: Latin America Apheresis Market Attractiveness Analysis, by Technology, 2024-2034
Figure 77: Latin America Apheresis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 78: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 79: Middle East & Africa Apheresis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 80: Middle East & Africa Apheresis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 81: Middle East & Africa Apheresis Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 82: Middle East & Africa Apheresis Market Value Share Analysis, by Application, 2023 and 2034
Figure 83: Middle East & Africa Apheresis Market Value Share Analysis, by Procedure, 2023 and 2034
Figure 84: Middle East & Africa Apheresis Market Value Share Analysis, by Technology, 2023 and 2034
Figure 85: Middle East & Africa Apheresis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 86: Middle East & Africa Apheresis Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 87: Middle East & Africa Apheresis Market Attractiveness Analysis, by Application, 2024-2034
Figure 88: Middle East & Africa Apheresis Market Attractiveness Analysis, by Procedure, 2023-2034
Figure 89: Middle East & Africa Apheresis Market Attractiveness Analysis, by Technology, 2024-2034
Figure 90: Middle East & Africa Apheresis Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Apheresis Market
*86 figures and 60 tables includes